Shihong Li

432 total citations
16 papers, 340 citations indexed

About

Shihong Li is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Shihong Li has authored 16 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Shihong Li's work include Medical Imaging Techniques and Applications (8 papers), PARP inhibition in cancer therapy (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Shihong Li is often cited by papers focused on Medical Imaging Techniques and Applications (8 papers), PARP inhibition in cancer therapy (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Shihong Li collaborates with scholars based in United States, United Kingdom and China. Shihong Li's co-authors include Robert H. Mach, David A. Mankoff, Brian P. Lieberman, Catherine Hou, Hsiaoju Lee, Chenbo Zeng, Chi-Chang Weng, Mark A. Sellmyer, Austin R. Pantel and Rong Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Molecules.

In The Last Decade

Shihong Li

15 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shihong Li United States 8 125 100 93 88 56 16 340
Blanca L. Valle United States 8 169 1.4× 163 1.6× 71 0.8× 92 1.0× 34 0.6× 12 437
Ziwei Tu China 12 186 1.5× 25 0.3× 101 1.1× 106 1.2× 61 1.1× 31 415
Brandon Cooper United States 9 112 0.9× 33 0.3× 100 1.1× 113 1.3× 43 0.8× 22 336
Massimo Gion Italy 5 154 1.2× 91 0.9× 108 1.2× 160 1.8× 15 0.3× 8 327
Mamta Parikh United States 11 150 1.2× 94 0.9× 59 0.6× 172 2.0× 55 1.0× 62 429
Evan Nair‐Gill United States 11 129 1.0× 91 0.9× 49 0.5× 169 1.9× 19 0.3× 17 415
Ingrid Babel Spain 8 301 2.4× 135 1.4× 84 0.9× 137 1.6× 17 0.3× 9 483
Laurie Freire Boullosa Belgium 8 137 1.1× 83 0.8× 43 0.5× 91 1.0× 15 0.3× 11 331
Ruizhan Tong China 11 211 1.7× 35 0.3× 75 0.8× 203 2.3× 45 0.8× 20 450
Mau‐Shin Chi Taiwan 9 117 0.9× 36 0.4× 63 0.7× 62 0.7× 35 0.6× 17 327

Countries citing papers authored by Shihong Li

Since Specialization
Citations

This map shows the geographic impact of Shihong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shihong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shihong Li more than expected).

Fields of papers citing papers by Shihong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shihong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shihong Li. The network helps show where Shihong Li may publish in the future.

Co-authorship network of co-authors of Shihong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shihong Li. A scholar is included among the top collaborators of Shihong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shihong Li. Shihong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hensley, Christopher T., Prashanth K. Padakanti, Hoon Choi, et al.. (2025). L-5-[11C]-glutamine PET of breast cancer: Preclinical studies in mouse models. Nuclear Medicine and Biology. 150-151. 109092–109092.
2.
Pantel, Austin R., Mahsa Kiani, Robert K. Doot, et al.. (2024). Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate–Ribose) Polymerase-1–Targeted18F-Fluorthanatrace PET in Breast Cancer. Journal of Nuclear Medicine. 65(12). jnumed.124.268254–jnumed.124.268254. 2 indexed citations
3.
Guarnieri, Joseph W., Douglas C. Wallace, Shihong Li, et al.. (2024). PET Imaging with [18F]ROStrace Detects Oxidative Stress and Predicts Parkinson’s Disease Progression in Mice. Antioxidants. 13(10). 1226–1226. 3 indexed citations
4.
Zhang, Zhendong, Lixia Bai, Zhe Qin, et al.. (2023). The Transport and Uptake of Resveratrol Mediated via Glucose Transporter 1 and Its Antioxidant Effect in Caco-2 Cells. Molecules. 28(12). 4569–4569. 5 indexed citations
5.
Hsieh, Chia‐Ju, Catherine Hou, Yi Zhu, et al.. (2022). [18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice. EJNMMI Research. 12(1). 43–43. 8 indexed citations
6.
Pantel, Austin R., Varsha Viswanath, Mehran Makvandi, et al.. (2021). Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1–Targeted 18F-Fluorthanatrace PET Images of Ovarian Cancer. Journal of Nuclear Medicine. 63(1). 44–50. 14 indexed citations
7.
Viswanath, Varsha, Rong Zhou, Hsiaoju Lee, et al.. (2020). Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism. Journal of Nuclear Medicine. 62(8). 1154–1162. 23 indexed citations
8.
Padakanti, Prashanth K., Shihong Li, Alexander Schmitz, et al.. (2019). Automated synthesis of [11C]L-glutamine on Synthra HCN plus synthesis module. EJNMMI Radiopharmacy and Chemistry. 4(1). 5–5. 7 indexed citations
9.
Doot, Robert K., Jacob G. Dubroff, Joshua Scheuermann, et al.. (2018). Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride. EJNMMI Physics. 5(1). 21–21. 6 indexed citations
10.
Reilly, Sean W., Laura N. Puentes, Alexander Schmitz, et al.. (2018). Synthesis and evaluation of an AZD2461 [18F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant. Bioorganic Chemistry. 83. 242–249. 18 indexed citations
11.
Zhou, Rong, Austin R. Pantel, Shihong Li, et al.. (2017). [18F](2 S ,4 R )4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition. Cancer Research. 77(6). 1476–1484. 81 indexed citations
12.
Sellmyer, Mark A., Catherine Hou, Chi-Chang Weng, et al.. (2017). Bacterial infection imaging with [ 18 F]fluoropropyl-trimethoprim. Proceedings of the National Academy of Sciences. 114(31). 8372–8377. 103 indexed citations
13.
Makvandi, Mehran, Lauren E. Schwartz, Kuiying Xu, et al.. (2017). Abstract 3716: Exploring the significance of PARP-1 expression for therapy and clinical PET/CT imaging of PARP-1 in ovarian cancer. Cancer Research. 77(13_Supplement). 3716–3716. 2 indexed citations
15.
Edmonds, Christine E., Mehran Makvandi, Brian P. Lieberman, et al.. (2016). [(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer.. PubMed. 6(1). 94–101. 47 indexed citations
16.
Ren, Yuanyuan, Yongzhe Liu, Yuping Ding, et al.. (2013). Immune characteristics of different immune phases in natural course of chronic HBV infection.. PubMed. 60(124). 789–95. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026